157 related articles for article (PubMed ID: 11742900)
1. Fluoroquinolones for respiratory infections: too valuable to overuse.
Williams JH
Chest; 2001 Dec; 120(6):1771-5. PubMed ID: 11742900
[No Abstract] [Full Text] [Related]
2. Fluoroquinolones for respiratory infection: too valuable to overuse (and too valuable to misuse!).
Weiss K; Tillotson GS
Chest; 2002 Sep; 122(3):1102-3; author reply 1103. PubMed ID: 12226065
[No Abstract] [Full Text] [Related]
3. Community-acquired lower respiratory tract infections: etiology and treatment.
Guthrie R
Chest; 2001 Dec; 120(6):2021-34. PubMed ID: 11742937
[TBL] [Abstract][Full Text] [Related]
4. Newer fluoroquinolones and the management of respiratory tract infections.
Karchmer AW
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S15. PubMed ID: 10984322
[No Abstract] [Full Text] [Related]
5. [The role of quinolones in the treatment of community acquired pneumonia].
Garau J
Med Clin (Barc); 1998 Feb; 110 Suppl 1():31-5. PubMed ID: 9717158
[No Abstract] [Full Text] [Related]
6. [The place of the new quinolones in the guidelines on the treatment of community-acquired pneumonia].
Dorca J
Arch Bronconeumol; 1999 May; 35 Suppl 3():77-80. PubMed ID: 10410230
[No Abstract] [Full Text] [Related]
7. A review of worldwide experience with sparfloxacin in the treatment of community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis.
Finch RG
Int J Antimicrob Agents; 1999 Jun; 12(1):5-17. PubMed ID: 10389642
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin.
Landen H; Möller M; Tillotson GS; Kubin R; Höffken G
J Int Med Res; 2001; 29(2):51-60. PubMed ID: 11393349
[TBL] [Abstract][Full Text] [Related]
9. [The antibacterial therapy of community-acquired pneumonia].
Khveshchuk PF; Rakov AL; Sinopal'nikov AI; Rudakova AV
Voen Med Zh; 1999 Jan; 320(1):25-36. PubMed ID: 10200622
[No Abstract] [Full Text] [Related]
10. New insights in the treatment by levofloxacin.
File TM
Chemotherapy; 2004; 50 Suppl 1():22-8. PubMed ID: 15319551
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin (Avelox): an 8-methoxyquinolone antibacterial with enhanced potency.
Ball P
Int J Clin Pract; 2000 Jun; 54(5):329-32. PubMed ID: 10954961
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections.
Blasi F; Tarsia P; Cosentini R; Cazzola M; Allegra L
Expert Opin Investig Drugs; 2003 Jul; 12(7):1165-77. PubMed ID: 12831351
[TBL] [Abstract][Full Text] [Related]
13. Drug not considered a first-line agent.
Lexchin J
Can Fam Physician; 1998 Nov; 44():2376. PubMed ID: 9839049
[No Abstract] [Full Text] [Related]
14. Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studies.
Grassi GG; Brumpt I
Drugs; 1995; 49 Suppl 2():406-8. PubMed ID: 8549379
[No Abstract] [Full Text] [Related]
15. Journal of Managed Care Pharmacy. START (Stewardship Tactics for Antimicrobial Resistance Trends). Introduction.
Rodvold KA
J Manag Care Pharm; 2009 Mar; 15(2 Suppl):S3-4. PubMed ID: 19358369
[No Abstract] [Full Text] [Related]
16. Clinical assessment of tosufloxacin tosilate.
Kohno S
J Infect Chemother; 2002 Mar; 8(1):19-27. PubMed ID: 11957115
[No Abstract] [Full Text] [Related]
17. New antibiotic approved for community-acquired infections.
Nurse Pract; 1998 Jan; 23(1):94. PubMed ID: 9470200
[No Abstract] [Full Text] [Related]
18. Fluoroquinolones for the treatment of outpatient community-acquired pneumonia.
Jones RN; Mandell LA
Diagn Microbiol Infect Dis; 2002 Sep; 44(1):69-76. PubMed ID: 12376035
[TBL] [Abstract][Full Text] [Related]
19. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
Garin N; Nendaz M
Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046
[TBL] [Abstract][Full Text] [Related]
20. Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs).
Blasi F
J Chemother; 2004 Apr; 16 Suppl 2():11-4. PubMed ID: 15255556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
